S1501 Real-World Switch Rates, Adherence, and Corticosteroid Use Among Tumor Necrosis Factor Inhibitor-Experienced Patients With UC Initiating Upadacitinib Relative to Those Initiating Ustekinumab, Vedolizumab, and Tofacitinib
Year: 2025
Type: conference-abstract
Authors: Corey A. Siegel, Ryan Ungaro, Jae Rok Kim, Nidhi Shukla, Cecile Holweg, Lisa Malter, Raymond K. Cross
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7110805182
Cites:
Cited by:
Related to: